SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
acel12108-sup-0001-FigsS1-S12-TablesS1-S10.pdfapplication/PDF4092K

Fig. S1 Schematic of ΔNp53:WTp53.

Fig. S2 Representative Western blot and cell cycle data.

Fig. S3 Assessment of apoptosis, growth, and senescence

Fig. S4 GSEA of microarray data.

Fig. S5 Venn diagrams of gene expression data.

Fig. S6 qRT–PCR validation of microarray data.

Fig. S7 qRT–PCR data from Saos-2 cells.

Fig. S8 Evaluation of WTp53:WTp53 tetramers.

Fig. S9 qRT–PCR data comparing ΔNp53:WTp53 with ΔNp53 and WTp53 coexpressed at equal levels.

Fig. S10 Comparison of ΔNp53-induced gene expression changes in H1299 cells.

Fig. S11 Additional data for mitochondrial function.

Fig. S12 Additional data for mTOR pathway.

Table S1 Genes up-regulated 1.5-fold or greater in H1299 cells expressing ΔNp53:WTp53, compared with WTp53.

Table S2 Genes down-regulated 1.5-fold or greater in H1299 cells expressing ΔNp53:WTp53, compared with WTp53.

Table S3 Overview of metabolomics data.

Table S4 Metabolomics data.

Table S5 Summary of metabolic changes induced by WTp53.

Table S6 Pathway analysis of gene expression data: GO Processes and GO Metabolic Networks.

Table S7 Pathway analysis of gene expression data: GO Pathways.

Table S8 Pathway analysis of Metabolomics data.

Table S9 Merged Pathway analysis of gene expression and metabolomics data.

Table S10 Primer sequences used for cloning and qRT–PCR.

Data S1 Experimental procedures.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.